MK

Molumuri Kalyan

Active Director Director DIN 11565688
DIN 11565688 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Molumuri Kalyan

Data last updated:

Molumuri Kalyan is a Director at K&K Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11565688
Primary Designation Director
Industry Pharma
First Appointment 23 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
K&K Pharmaceuticals Private Limited U46497TS2026PTC211966
Director23 Feb 20262026Active

Board colleagues of Molumuri Kalyan

NameDINCompanyDesignation
Krishna Swamy Chata11565687K&K Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
K&K Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Molumuri Kalyan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Molumuri Kalyan

Molumuri Kalyan currently holds 1 directorship: K&K Pharmaceuticals Private Limited (Director, since 23 Feb 2026).

Molumuri Kalyan was first appointed on 23 Feb 2026 as Director at K&K Pharmaceuticals Private Limited.

The current boards of Molumuri Kalyan's companies include Krishna Swamy Chata (K&K Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available